Cabaletta Bio (CABA) Earnings Analysis
Cabaletta Bio (CABA) next reports earnings on 2026-08-06, consensus EPS -0.37 USD. Last quarter (2026-05-14) it beat with EPS -0.39 USD vs -0.41 USD est (+4.9%). It has beaten estimates in 4/8 recent quarters (50%). Trailing P/E -1.40.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CABA next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -0.37 USD |
| Revenue estimate | 0.00B |
CABA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -0.39 USD | -0.41 USD | +4.9% | Beat |
| 2026-03-23 | -0.4 USD | -0.45 USD | +11.1% | Beat |
| 2025-11-10 | -0.44 USD | -0.49 USD | +10.2% | Beat |
| 2025-08-07 | -0.73 USD | -0.71 USD | -2.8% | Miss |
| 2025-05-15 | -0.71 USD | -0.67 USD | -6% | Miss |
| 2025-03-31 | -0.65 USD | -0.65 USD | 0% | Beat |
| 2024-11-14 | -0.62 USD | -0.59 USD | -5.1% | Miss |
| 2024-08-08 | -0.56 USD | -0.55 USD | -1.8% | Miss |
Beat rate: 4/8 (50%) over reported quarters with consensus data.
CABA valuation and analyst view
| Trailing P/E | -1.40 |
|---|---|
| Trailing EPS | -1.56597 USD |
| Price / book | 2.98 |
| Dividend yield | 0.00% |
| Market cap | 0.44B |
| Analyst consensus | Buy (10 buy / 2 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Cabaletta Bio (CABA)'s next earnings date?
Cabaletta Bio is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.37 USD and revenue estimate of 0.00B.
Did CABA beat earnings last quarter?
In its 2026-05-14 report, CABA posted EPS of -0.39 USD versus a -0.41 USD estimate — a beat of 4.9%.
What is CABA's earnings track record?
Over the last 8 reported quarters with consensus data, CABA beat estimates 4 times (50%).
What is CABA's current P/E ratio and EPS?
CABA trades at a trailing P/E of -1.40 on trailing EPS of -1.5659652553668284 USD.
What do analysts rate CABA?
Analyst consensus is "Buy" across 12 ratings (0 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell).